Colin Macleod
Overview
Explore the profile of Colin Macleod including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
161
Citations
3056
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Notebaert L, Harris R, Macleod C, Crane M, Bucks R
PeerJ
. 2024 Sep;
12:e17911.
PMID: 39221278
Background: Resilience refers to the process of demonstrating better outcomes than would be expected based on the adversity one experienced. Resilience is increasingly measured using a residual approach, which typically...
2.
Lee D, Mercer O, Halai V, Gill L, Macleod C, Lampejo T
Clin Med (Lond)
. 2024 Aug;
24(5):100239.
PMID: 39208983
Measles is a highly contagious but vaccine-preventable airborne-transmitted viral infection of which there has been a recent resurgence of cases worldwide over the past year, including in countries such as...
3.
Vrijsen J, Grafton B, Koster E, Lau J, Wittekind C, Bar-Haim Y, et al.
Behav Res Ther
. 2024 May;
179():104557.
PMID: 38797055
Cognitive bias modification (CBM) has evolved from an experimental method testing cognitive mechanisms of psychopathology to a promising tool for accessible digital mental health care. While we are still discovering...
4.
Reynolds A, Macleod C, Grafton B
Behav Res Ther
. 2024 May;
179:104568.
PMID: 38768554
The present study examined cognitive mechanisms underpinning the increased tendency of individuals with high trait anxiety to experience inflation of negative affect when approaching potential stressors. Specifically, the roles of...
5.
Irani E, Macleod C, Slat S, Kehne A, Madden E, Jaffe K, et al.
Drug Alcohol Depend Rep
. 2024 May;
11():100235.
PMID: 38737490
Purpose: Negative perceptions around medications for opioid use disorder (MOUD) amongst the public could deter patients with opioid use disorder (OUD) from engaging with MOUD. Thus, we evaluated whether a...
6.
Jaffe K, Slat S, Chen L, Macleod C, Bohnert A, Lagisetty P
J Subst Use Addict Treat
. 2024 May;
163:209361.
PMID: 38703949
Introduction: Medications for opioid use disorder (MOUD) including methadone (MMT), buprenorphine (BUP), and naltrexone (NTX) are safe and effective. However, there are significant negative perceptions surrounding MOUD, creating barriers to...
7.
Ji J, Macleod C
Behav Res Ther
. 2024 Apr;
177:104526.
PMID: 38598897
This study experimentally investigated the role of anticipated enjoyment and effort in mediating dysphoria-related deficit in activity engagement behavioural choice. Using a novel activity information processing task (about a fictional...
8.
Troeung L, Sarunga Raja T, Mann G, Wagland J, Macleod C, Martini A
BMJ Open
. 2024 Mar;
14(3):e080030.
PMID: 38508623
Introduction: This protocol describes the study which aims to: (1) develop an online psychoeducation platform for people with traumatic brain injury (TBI), their family members/caregivers, and healthcare staff to improve...
9.
Chung D, Slat S, Rao A, Thomas J, Kehne A, Macleod C, et al.
Subst Use
. 2024 Mar;
18:11782218241234808.
PMID: 38433746
Objectives: Stigma and lack of knowledge are barriers to clinicians when caring for individuals with opioid use disorder (OUD). In 2018, only about 15 out of 180 American medical schools...
10.